These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10428418)

  • 1. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the delta opioid system in the nucleus accumbens of rat.
    Daugé V; Samir A; Cupo A; Roques BP
    Neuropharmacology; 1999 Jul; 38(7):999-1007. PubMed ID: 10428418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
    Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
    Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of D2 dopamine receptors in the opposing effects of two CCK-B agonists in a spatial recognition memory task: role of the anterior nucleus accumbens.
    Léna I; Dh tel H; Garbay C; Daugé V
    Psychopharmacology (Berl); 2001 Jan; 153(2):170-9. PubMed ID: 11205416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites.
    Ladurelle N; Sebret A; Garbay C; Roques BP; Daugé V
    Br J Pharmacol; 1998 Jul; 124(6):1091-8. PubMed ID: 9720778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Ladurelle N; Keller G; Roques BP; Daugé V
    Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101.
    Dauge V; Corringer PJ; Roques BP
    Pharmacol Biochem Behav; 1995 Feb; 50(2):133-9. PubMed ID: 7740050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat.
    Borg PJ; Taylor DA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):582-8. PubMed ID: 9151296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens.
    Schad CA; Justice JB; Holtzman SG
    J Neurochem; 1996 Dec; 67(6):2292-9. PubMed ID: 8931460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats.
    Daugé V; Derrien M; Blanchard JC; Roques BP
    Neuropharmacology; 1992 Jan; 31(1):67-75. PubMed ID: 1542405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mu- and delta-opioid-receptor antagonists on the stimulus properties of cholecystokinin.
    Riley AL; Melton PM
    Pharmacol Biochem Behav; 1997; 57(1-2):57-62. PubMed ID: 9164554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.
    Li Y; Li JJ; Yu LC
    Brain Res; 2002 Jun; 940(1-2):69-78. PubMed ID: 12020877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual modulation of dopamine release from anterior nucleus accumbens through cholecystokinin-B receptor subsites.
    Léna I; Roques BP; Durieux C
    J Neurochem; 1997 Jan; 68(1):162-8. PubMed ID: 8978722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive enhancing effects in young and old rats of pBC264, a selective CCK(B) receptor agonist.
    Taghzouti K; Léna I; Dellu F; Roques BP; Daugé V; Simon H
    Psychopharmacology (Berl); 1999 Apr; 143(2):141-9. PubMed ID: 10326776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylation of opioid receptors by 5'-naltrindole-isothiocyanate injected into the nucleus accumbens of rats: receptor selectivity and anatomical diffusion.
    Martin TJ; McIntosh S; Smith JE
    Synapse; 2006 Oct; 60(5):384-91. PubMed ID: 16847946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release.
    Acquas E; Meloni M; Di Chiara G
    Eur J Pharmacol; 1993 Jan; 230(2):239-41. PubMed ID: 8380771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta(2)-opioid receptor mediation of morphine-induced CCK release in the frontal cortex of the freely moving rat.
    Becker C; Hamon M; Cesselin F; Benoliel JJ
    Synapse; 1999 Oct; 34(1):47-54. PubMed ID: 10459171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264.
    Dauge V; Bohme GA; Crawley JN; Durieux C; Stutzmann JM; Feger J; Blanchard JC; Roques BP
    Synapse; 1990; 6(1):73-80. PubMed ID: 2399491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
    Lanza M; Makovec F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.